(NewsDirect)
Zynex Inc Founder and CEO Thomas Sandgaardjoined Steve Darling from Proactive to share news the company has beenrecognized as one of the Top 100 Healthcare Technology Companies of2023 by The Healthcare Technology Report.
Zynex secured the 23rd spot on the list, marking its secondconsecutive appearance in the top 100. Sandgaard says this is thesecond year in a row that Zynex has received recognition in TheHealthcare Technology Report's top 100 list. In the previous year,the company was ranked 33rd.
Zynex's consistent presence on this prestigious listunderscores its ongoing commitment to innovation and excellence inhealthcare technology. The company has a focus on pain management andhospital monitoring products.
Whileboth divisions are important, the company's primary revenue sourcelies in pain management, where they've maintained a successfulbusiness model for 27 years. Their pain management therapies areside-effect-free and covered by insurance companies, leading toimpressive annual revenues, expected to exceed $200 million in thenear future.
The profitability ofthe pain management division enables Zynex to fund the development ofproducts in the monitoring division. This financial strength andproduct diversity attract various types of investors, both retail andinstitutional.
Zynex's recent financial performance hasbeen outstanding, with consistent growth and successful quarterlyresults, continually surpassing analyst estimates. Zynex's futuregrowth primarily hinges on its pain management division, withsignificant revenue expected in the coming years.
ContactDetails
Proactive Investors
+1 604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.